Food & AgricultureFintechBiotech & Life SciencesClimate & EnergyManufacturingMarketing & AdvertisingHealthcareMobility & TransportationPropTechHR & Talent
Capital Grand Est is an independent private equity and venture capital management firm based in Schiltigheim, France. Founded in 2012, it invests in startups and SMEs across multiple sectors and stages of maturity in the Grand Est region of France.
60% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (60% of deals).
Portfolio
5
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
FT
Florence Trinquet-Cirilli
Partner
FL
François Lory
Partner
JR
Jean-François Rax
Partner
TM
Tiphanie Maier
Investment Director
VC
Victor CHAN
VC Investment Director
VM
Virginie MIATH
Investment Director
JR
Jérémy RICHARD
Directeur de participations
MB
Marc Beekenkamp
Directeur de participations
SB
Stéphane BECKER
Directeur Associé
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Elkedonia | Seed | — | Jun 2025 |
 Keey Aerogel | Series A | — | Jan 2025 |
 Exeliom Biosciences | Series A | — | Jul 2023 |
 APMONIA THERAPEUTICS | Series A | — | Feb 2022 |
 SIRFULL | Seed | $6M | — |
Top Co-Investors
Bpifrance1 shared
Angelini Ventures1 shared
EQT Life Sciences1 shared
Carma Fund1 shared
French Tech Seed Fund1 shared
Kurma Partners1 shared
Innovation Global Capital1 shared
Wind1 shared
Demea Invest1 shared
Innovacom1 shared
Demeter1 shared
Wille Finance1 shared
Raga Partners1 shared
Crescent Capital Group1 shared
Biocodex1 shared
Crescent Enterprises1 shared
UI Investissement1 shared
CE Ventures1 shared
Headline1 shared
Last updated: 27 September 2026